TGTX
#1004
TG Therapeutics, Inc. - Common Stock
56.4 1 USD
+0.03%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.77%
Changement Mensuel
+10.87%
Evolution sur 6 mois
+87.97%
Changement Annuel
+45.50%
Clôture Précédente
54.8 9
Open
56.4 1
Low
56.4 1
High
56.4 1
Volume
107
Financials
- Market Capitalization 8.64 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
11.62
ratio cours/chiffre d'affaires
7.64
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 990 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.90 USD | +0.23% | +0.47% | +139.71% | +104.14% | 8.85 B USD | ||
| 997 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 135.46 USD | +3.19% | -2.73% | +22.21% | +80.30% | 8.71 B USD | ||
| 1020 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.29 USD | +0.25% | +0.74% | +57.30% | +150.59% | 8.31 B USD | ||
| 1026 |  PCVX Vaxcyte, Inc. - Common Stock | 56.74 USD | +0.94% | -3.52% | +14.97% | +34.14% | 8.19 B USD |